Bovicin HJ50-like lantibiotics, a novel subgroup of lantibiotics featured by an indispensable disulfide bridge

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Wang, Jian ^a,b   Ma, Hongchu ^a,b   Ge, Xiaoxuan ^a,b   Zhang, Jie ^a,b   Teng, Kunling ^a   Sun, Zhizeng ^a,c   Zhong, Jin ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVICIN HJ50; CERECIN; LANTIBIOTIC; PERECIN; THURICIN; UNCLASSIFIED DRUG; BACTERIOCIN; BOVICIN HJ50, STREPTOCOCCUS BOVIS; DISULFIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACILLUS THURINGIENSIS; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DISULFIDE BOND; GENE CLUSTER; GROWTH INHIBITION; HYDROPHOBICITY; MEMBRANE DAMAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN SECONDARY STRUCTURE; STREPTOCOCCUS BOVIS; AMINO ACID SEQUENCE; CELL MEMBRANE; CHEMICAL PHENOMENA; CHEMISTRY; DATA MINING; DRUG EFFECTS; GENE LOCUS; GENETIC DATABASE; GENETICS; GENOMICS; MOLECULAR GENETICS; MULTIGENE FAMILY; STREPTOCOCCUS EQUINUS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; BACTERIOCINS; CELL MEMBRANE; DATA MINING; DATABASES, GENETIC; DISULFIDES; GENETIC LOCI; GENOMICS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PROTEIN STRUCTURE, SECONDARY; STREPTOCOCCUS BOVIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901278389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097121     Document Type: Article

References (40)

1. Hancock RE, Sahl H-G (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
2. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720.
3. Héchard Y, Sahl H-G (2002) Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 84: 545-557.
4. Fimland G, Johnsen L, Dalhus B, Nissen-Meyer J (2005) Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action. J Pept Sci 11: 688-696.
5. Willey JM, van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61: 477-501.
6. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, et al. (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30: 108-160.
7. Meindl K, Schmiederer T, Schneider K, Reicke A, Butz D, et al. (2010) Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed Engl 49: 1151-1154.
8. Ökesli Ae, Cooper LE, Fogle EJ, van der Donk WA (2011) Nine post-translational modifications during the biosynthesis of cinnamycin. J Am Chem Soc 133: 13753-13760.
9. Sit CS, Yoganathan S, Vederas JC (2011) Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates. Acc Chem Res 44: 261-268.
10. McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, et al. (2006) Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci U S A 103: 17243-17248.
11. Holo H, Jeknic Z, Daeschel M, Stevanovic S, Nes IF (2001) Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiol 147: 643-651.
12. Sawa N, Wilaipun P, Kinoshita S, Zendo T, Leelawatcharamas V, et al. (2012) Isolation and Characterization of Enterocin W, a Novel Two-Peptide Lantibiotic Produced by Enterococcus faecalis NKR-4-1. Appl Environ Microbiol 78: 900-903.
13. Xiao H, Chen X, Chen M, Tang S, Zhao X, et al. (2004) Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50. Microbiol 150: 103-108.
14. Lin Y, Teng K, Huan L, Zhong J (2011) Dissection of the bridging pattern of bovicin HJ50, a lantibiotic containing a characteristic disulfide bridge. Microbiol Res 166: 146-154.
15. Kabuki T, Uenishi H, Seto Y, Yoshioka T, Nakajima H (2009) A unique lantibiotic, thermophilin 1277, containing a disulfide bridge and two thioether bridges. J Appl Microbiol 106: 853-862.
16. Georgalaki M, Papadimitriou K, Anastasiou R, Pot B, Van Driessche G, et al. (2013) Macedovicin, the second food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Food Microbiol 33: 124-130.
17. Wang J, Gao Y, Teng K, Zhang J, Sun S, et al. (2014) Restoration of Bioactive Lantibiotic Suicin from a Remnant lan Locus of Pathogenic Streptococcus suis Serotype 2. Appl Environ Microbiol 80: 1062-1071.
18. Shi Y, Yang X, Garg N, van der Donk WA (2010) Production of lantipeptides in Escherichia coli. J Am Chem Soc 133: 2338-2341.
19. Sun Z, Zhong J, Liang X, Liu J, Chen X, et al. (2009) Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR. Antimicrob Agents Chemother 53: 1964-1973.
20. Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, et al. (2005) Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook: Springer. pp. 571-607.
21. Begley M, Cotter PD, Hill C, Ross RP (2009) Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol 75: 5451-5460.
22. van Heel AJ, de Jong A, Montalban-Lopez M, Kok J, Kuipers OP (2013) BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides. Nucleic Acids Res doi:10.1093/nar/gkt391.
23. Marsh AJ, O'Sullivan O, Ross RP, Cotter PD, Hill C (2010) In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics 11: 679.
24. Rink R, Kuipers A, de Boef E, Leenhouts KJ, Driessen AJ, et al. (2005) Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochemistry 44: 8873-8882.
25. Patton GC, Paul M, Cooper LE, Chatterjee C, van der Donk WA (2008) The Importance of the Leader Sequence for Directing Lanthionine Formation in Lacticin 481. Biochemistry 47: 7342-7351.
26. Islam MR, Nishie M, Nagao J-i, Zendo T, Keller S, et al. (2012) Ring A of nukacin ISK-1: a lipid II-binding motif for type-A (II) lantibiotic. J Am Chem Soc 134: 3687-3690.
27. Knerr PJ, Oman TJ, Garcia De Gonzalo CV, Lupoli TJ, Walker S, et al. (2012) Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation. ACS Chem Biol 7: 1791-1795.
28. Liu G, Zhong J, Ni J, Chen M, Xiao H, et al. (2009) Characteristics of the bovicin HJ50 gene cluster in Streptococcus bovis HJ50. Microbiol 155: 584-593.
29. Xie L, Miller LM, Chatterjee C, Averin O, Kelleher NL, et al. (2004) Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science 303: 679-681.
30. Yount NY, Yeaman MR (2004) Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci U S A 101: 7363-7368.
31. Derksen DJ, Boudreau MA, Vederas JC (2008) Hydrophobic interactions as substitutes for a conserved disulfide linkage in the type IIa bacteriocins, leucocin A and pediocin PA-1. Chembiochem 9: 1898-1901.
32. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, et al. (2011) Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature 469: 419-423.
33. Teng K, Zhang J, Zhang X, Ge X, Gao Y, et al. (2014) Identification of Ligand Specificity Determinants in Lantibiotic Bovicin HJ50 and the Receptor BovK, a Multi-transmembrane Histidine Kinase. J Biol Chem 289: 9823-9832.
34. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: Cold spring harbor laboratory press New York.
35. Wang J, Zhang L, Teng K, Sun S, Sun Z, et al. (2014) Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity. Appl Environ Microbiol 80(8):2633-2643.
36. Chiu J, March PE, Lee R, Tillett D (2004) Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h. Nucleic Acids Res 32: e174.
37. Schägger H (2006) Tricine-SDS-PAGE. Nature protocols 1: 16-22.
38. Levengood MR, Knerr PJ, Oman TJ, van der Donk WA (2009) In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids. J Am Chem Soc 131: 12024-12025.
39. Tulumello DV, Deber CM (2009) SDS micelles as a membrane-mimetic environment for transmembrane segments. Biochemistry 48: 12096-12103.
40. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, et al. (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328: 1168-1172.